Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Xanthoma in Alagille Syndrome
NCT05488067Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Mar 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in Xanthoma, Alagille syndrome (ALGS), sponsored by Children's Hospital of Fudan University. Started Mar 2022; status: completed.
02
Drugs
atorvastatin
03
Conditions
XanthomaAlagille syndrome (ALGS)
Beyond the preview
Go deeper on NCT05488067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05488067.